Janet Vergis - Dentsply Sirona Independent Director
| DY2 Stock | EUR 18.16 0.29 1.57% |
Director
Janet Vergis is Independent Director of Dentsply Sirona since 2019.
| Age | 54 |
| Tenure | 5 years |
| Phone | 844-848-0137 |
| Web | https://www.dentsplysirona.com |
Janet Vergis Latest Insider Activity
Tracking and analyzing the buying and selling activities of Janet Vergis against Dentsply Sirona stock is an integral part of due diligence when investing in Dentsply Sirona. Janet Vergis insider activity provides valuable insight into whether Dentsply Sirona is net buyers or sellers over its current business cycle. Note, Dentsply Sirona insiders must abide by specific rules, including filing SEC forms every time they buy or sell Dentsply Sirona'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Janet Vergis over a year ago Exercise or conversion by Janet Vergis of 15810 shares of Teva Pharma subject to Rule 16b-3 |
Dentsply Sirona Management Efficiency
The company has return on total asset (ROA) of 0.0345 % which means that it generated a profit of $0.0345 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2157) %, meaning that it generated substantial loss on money invested by shareholders. Dentsply Sirona's management efficiency ratios could be used to measure how well Dentsply Sirona manages its routine affairs as well as how well it operates its assets and liabilities.Management Performance
| Return On Equity | -0.22 | |||
| Return On Asset | 0.0345 |
Dentsply Sirona Leadership Team
Elected by the shareholders, the Dentsply Sirona's board of directors comprises two types of representatives: Dentsply Sirona inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Dentsply. The board's role is to monitor Dentsply Sirona's management team and ensure that shareholders' interests are well served. Dentsply Sirona's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Dentsply Sirona's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Richard Wagner, Chief Officer | ||
| Janet Vergis, Independent Director | ||
| Cheree Johnson, Chief VP | ||
| Lisa Yankie, Senior Vice President Chief Human Resources Officer and Communications | ||
| Francis Lunger, Independent Director | ||
| Jorge Gomez, Chief Financial Officer, Executive Vice President | ||
| Chidam Chidambaram, Senior Vice President Chief Digital Officer | ||
| Andrew Robinson, VP Officer | ||
| Ranjit Chadha, Chief Accounting Officer, Principal Accounting Officer | ||
| Andrea Daley, VP Relations | ||
| Harry Kraemer, Independent Director | ||
| Betsy Holden, Independent Director | ||
| Leslie Varon, Independent Director | ||
| Eric Brandt, Non-Executive Independent Chairman of the Board | ||
| Gregory Lucier, Independent Director | ||
| Donald Casey, Chief Executive Officer, Director | ||
| William Newell, Senior Vice President Chief Segment Officer | ||
| Andreas Frank, Ex Group | ||
| Willie Deese, Independent Director | ||
| Daniel Key, Senior Vice President Chief Supply Chain Officer | ||
| Simon Campion, Pres CEO | ||
| Erania Brackett, VP Officer | ||
| Walter Petersohn, Senior Vice President Chief Commercial Officer | ||
| Matthew Coggin, Senior Vice President Business Development and Strategy Officer | ||
| Keith Ebling, Executive Vice President General Counsel, Secretary | ||
| Michael Alfano, Independent Director | ||
| Clyde Hosein, Director | ||
| Cord Staehler, Senior Vice President, Chief Technology Officer | ||
| Arthur Kowaloff, Independent Director | ||
| Glenn Coleman, Ex CFO |
Dentsply Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Dentsply Sirona a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.22 | |||
| Return On Asset | 0.0345 | |||
| Profit Margin | (0.24) % | |||
| Operating Margin | 0.12 % | |||
| Current Valuation | 7.79 B | |||
| Shares Outstanding | 214.91 M | |||
| Shares Owned By Insiders | 0.60 % | |||
| Shares Owned By Institutions | 99.40 % | |||
| Price To Earning | 75.67 X | |||
| Price To Book | 1.80 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Dentsply Stock
When determining whether Dentsply Sirona offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dentsply Sirona's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dentsply Sirona Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dentsply Sirona Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dentsply Sirona. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Dentsply Stock please use our How to Invest in Dentsply Sirona guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.